Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 149

1.

Extended criteria for living donor liver transplantation in patients with advanced hepatocellular carcinoma.

Choi HJ, Kim DG, Na GH, Hong TH, You YK.

Transplant Proc. 2012 Mar;44(2):399-402. doi: 10.1016/j.transproceed.2012.01.019.

PMID:
22410027
2.

Clinical outcome in patients with hepatocellular carcinoma after living-donor liver transplantation.

Choi HJ, Kim DG, Na GH, Han JH, Hong TH, You YK.

World J Gastroenterol. 2013 Aug 7;19(29):4737-44. doi: 10.3748/wjg.v19.i29.4737.

3.
4.

Effectiveness of locoregional therapy before living donor liver transplantation in patients with hepatocellular carcinoma who meet the Milan criteria.

Kim JM, Kwon CH, Joh JW, Choi MS, Lee JH, Koh KC, Paik SW, Kim GS, Kim SJ, Lee SK, Yoo BC.

Transplant Proc. 2012 Mar;44(2):403-8. doi: 10.1016/j.transproceed.2012.01.067.

PMID:
22410028
5.

Living donor liver transplantation for hepatocellular carcinoma.

Isik B, Ince V, Karabulut K, Kayaalp C, Yilmaz S.

Transplant Proc. 2012 Jul-Aug;44(6):1713-6. doi: 10.1016/j.transproceed.2012.05.033.

PMID:
22841251
6.

AFP level and histologic differentiation predict the survival of patients with liver transplantation for hepatocellular carcinoma.

Yaprak O, Akyildiz M, Dayangac M, Demirbas BT, Guler N, Dogusoy GB, Yuzer Y, Tokat Y.

Hepatobiliary Pancreat Dis Int. 2012 Jun;11(3):256-61.

PMID:
22672818
7.

Expansion of selection criteria for patients with hepatocellular carcinoma in living donor liver transplantation.

Ito T, Takada Y, Ueda M, Haga H, Maetani Y, Oike F, Ogawa K, Sakamoto S, Ogura Y, Egawa H, Tanaka K, Uemoto S.

Liver Transpl. 2007 Dec;13(12):1637-44.

8.

Primary versus salvage living donor liver transplantation for patients with hepatocellular carcinoma: impact of microvascular invasion on survival.

Moon JI, Kwon CH, Joh JW, Choi GS, Jung GO, Kim JM, Shin M, Choi SJ, Kim SJ, Lee SK.

Transplant Proc. 2012 Mar;44(2):487-93. doi: 10.1016/j.transproceed.2011.11.009.

PMID:
22410053
9.

Rate of tumor growth predicts recurrence of hepatocellular carcinoma after liver transplantation in patients beyond Milan or UCSF criteria.

Hanouneh IA, Macaron C, Lopez R, Aucejo F, Zein NN.

Transplant Proc. 2011 Dec;43(10):3813-8. doi: 10.1016/j.transproceed.2011.09.043.

PMID:
22172852
10.

Predicting survival after liver transplantation using up-to-seven criteria in patients with hepatocellular carcinoma.

de Ataide EC, Garcia M, Mattosinho TJ, Almeida JR, Escanhoela CA, Boin IF.

Transplant Proc. 2012 Oct;44(8):2438-40. doi: 10.1016/j.transproceed.2012.07.006.

PMID:
23026614
11.

Extended indication for living donor liver transplantation in patients with hepatocellular carcinoma.

Soejima Y, Taketomi A, Yoshizumi T, Uchiyama H, Aishima S, Terashi T, Shimada M, Maehara Y.

Transplantation. 2007 Apr 15;83(7):893-9.

PMID:
17460559
12.

Impact of des-gamma-carboxy prothrombin and tumor size on the recurrence of hepatocellular carcinoma after living donor liver transplantation.

Taketomi A, Sanefuji K, Soejima Y, Yoshizumi T, Uhciyama H, Ikegami T, Harada N, Yamashita Y, Sugimachi K, Kayashima H, Iguchi T, Maehara Y.

Transplantation. 2009 Feb 27;87(4):531-7. doi: 10.1097/TP.0b013e3181943bee.

PMID:
19307789
13.

Living-donor liver transplantation associated with higher incidence of hepatocellular carcinoma recurrence than deceased-donor liver transplantation.

Park MS, Lee KW, Suh SW, You T, Choi Y, Kim H, Hong G, Yi NJ, Kwon CH, Joh JW, Lee SK, Suh KS.

Transplantation. 2014 Jan 15;97(1):71-7. doi: 10.1097/TP.0b013e3182a68953.

PMID:
24056623
14.

Living donor liver transplantation for hepatocellular carcinoma: Increased recurrence but improved survival.

Vakili K, Pomposelli JJ, Cheah YL, Akoad M, Lewis WD, Khettry U, Gordon F, Khwaja K, Jenkins R, Pomfret EA.

Liver Transpl. 2009 Dec;15(12):1861-6. doi: 10.1002/lt.21940.

15.

Section 5. Further expanding the criteria for HCC in living donor liver transplantation: when not to transplant: SNUH experience.

Lee KW, Yi NJ, Suh KS.

Transplantation. 2014 Apr 27;97 Suppl 8:S20-3. doi: 10.1097/01.tp.0000446269.20934.d3.

PMID:
24849825
16.
17.

Impact of tumour differentiation to select patients before liver transplantation for hepatocellular carcinoma.

Decaens T, Roudot-Thoraval F, Badran H, Wolf P, Durand F, Adam R, Boillot O, Vanlemmens C, Gugenheim J, Dharancy S, Bernard PH, Boudjema K, Calmus Y, Hardwigsen J, Ducerf C, Pageaux GP, Hilleret MN, Chazouillères O, Cherqui D, Mallat A, Duvoux C.

Liver Int. 2011 Jul;31(6):792-801. doi: 10.1111/j.1478-3231.2010.02425.x. Epub 2011 Mar 31.

PMID:
21645209
18.

Living donor liver transplantation in hepatocellular carcinoma beyond the Milan criteria.

Woo HY, Jang JW, Choi JY, You CR, Jeong SW, Bae SH, Yoon SK, Lee YS, Kim DG.

Liver Int. 2008 Sep;28(8):1120-8. doi: 10.1111/j.1478-3231.2008.01785.x. Epub 2008 May 20.

PMID:
18492023
19.

Liver transplantation for hepatocellular carcinoma using extended criteria donor grafts.

Sotiropoulos GC, Tagkalos E, Fouzas I, Vernadakis S, Mathé Z, Treckmann J, Paul A.

Transplant Proc. 2012 Nov;44(9):2730-3. doi: 10.1016/j.transproceed.2012.09.021.

PMID:
23146507
20.

Living donor liver transplantation for patients with HCC exceeding the Milan criteria: a proposal of expanded criteria.

Takada Y, Ito T, Ueda M, Sakamoto S, Haga H, Maetani Y, Ogawa K, Ogura Y, Oike F, Egawa H, Uemoto S.

Dig Dis. 2007;25(4):299-302.

PMID:
17960063

Supplemental Content

Support Center